APA (7th ed.) Citation

Christopoulos, P., Prawitz, T., Hong, J., Lin, H. M., Hernandez, L., Jin, S., . . . Stenzinger, A. (2023). Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations. Lung cancer, 179, . https://doi.org/10.1016/j.lungcan.2023.107191

Chicago Style (17th ed.) Citation

Christopoulos, Petros, et al. "Indirect Comparison of Mobocertinib and Real-world Therapies for Pre-treated Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations." Lung Cancer 179 (2023). https://doi.org/10.1016/j.lungcan.2023.107191.

MLA (9th ed.) Citation

Christopoulos, Petros, et al. "Indirect Comparison of Mobocertinib and Real-world Therapies for Pre-treated Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations." Lung Cancer, vol. 179, 2023, https://doi.org/10.1016/j.lungcan.2023.107191.